Drug intelligence / Profile preview

Floré Defense

Development stage: Unknown
Lead developer: Sun Genomics
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Recombinant Proteins and Enzymes, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Floré Defense is a branded **dietary supplement** developed and marketed by Sun Genomics under its Floré brand. It is a **multi-ingredient nutraceutical formulation** intended to support immune health and respiratory wellness, positioned around the gut-lung microbiome axis rather than as an FDA-approved therapeutic drug. The product is described as a custom blend containing **five probiotic strains together with prebiotics, elderberry, and vitamin C**; its intended activity is broad microbiome and immune support rather than a single defined pharmacologic target or validated disease-specific mechanism. It is sold for wellness and seasonal immune support, not as a pharmaceutical approved to diagnose, treat, cure, or prevent a specific disease.

Brand names: Floré Defense

Beyond the preview

Go deeper on Floré Defense.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Floré Defense.

Explore the full profile